These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35149994)

  • 1. Changes in the incidence of transfusion reactions in hematological patients over the past 30 years.
    Bojanić I; Lukić M; Plenković F; Raos M; Medenjak M; Ćepulić BG
    Transfusion; 2022 Mar; 62(3):600-611. PubMed ID: 35149994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
    King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
    Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet transfusion practice and related transfusion reactions in a large teaching hospital.
    Liker M; Bojanić I; Plenković F; Lukić M; Tomac G; Raos M; Golubić Ćepulić B
    Transfus Clin Biol; 2022 Feb; 29(1):37-43. PubMed ID: 34411746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.
    Pitman JP; Payrat JM; Park MS; Liu K; Corash L; Benjamin RJ
    Transfusion; 2023 Apr; 63(4):711-723. PubMed ID: 36802055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.
    Blumberg N; Heal JM; Gettings KF; Phipps RP; Masel D; Refaai MA; Kirkley SA; Fialkow LB
    Transfusion; 2010 Dec; 50(12):2738-44. PubMed ID: 20561296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO-incompatible platelets are associated with increased transfusion reaction rates.
    Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
    Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.
    Snyder EL; Wheeler AP; Refaai M; Cohn CS; Poisson J; Fontaine M; Sehl M; Nooka AK; Uhl L; Spinella P; Fenelus M; Liles D; Coyle T; Becker J; Jeng M; Gehrie EA; Spencer BR; Young P; Johnson A; O'Brien JJ; Schiller GJ; Roback JD; Malynn E; Jackups R; Avecilla ST; Lin JS; Liu K; Bentow S; Peng HL; Varrone J; Benjamin RJ; Corash LM
    Transfusion; 2022 Jul; 62(7):1365-1376. PubMed ID: 35748490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of complications after blood components' transfusions.
    Timler D; Klepaczka J; Kasielska-Trojan A; Bogusiak K
    Pol Przegl Chir; 2015 Apr; 87(4):166-73. PubMed ID: 26146115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing transfusion reactions between pre-storage and post-storage leukoreduced apheresis platelets: an analysis using propensity score matching.
    Chien SH; Huang HY; Chen YJ; Tsai YC; Lu SH; Lee LH; Liu HM; Chen WC; Liu YC; Lin TA; Liu CY
    Ann Hematol; 2024 Apr; 103(4):1389-1396. PubMed ID: 38393657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion reactions: A retrospective analysis of the Iranian national haemovigilance system (INHS) data.
    Mardani A; Balali MR
    Transfus Apher Sci; 2020 Aug; 59(4):102767. PubMed ID: 32280036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.
    Yamanaka M; Yanagisawa R; Kojima S; Nakazawa H; Shimodaira S
    Transfusion; 2019 Nov; 59(11):3405-3412. PubMed ID: 31532542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
    Oakley FD; Woods M; Arnold S; Young PP
    Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
    Sharma DK; Datta S; Gupta A
    Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs.
    Bruce JA; Kriese-Anderson L; Bruce AM; Pittman JR
    J Vet Emerg Crit Care (San Antonio); 2015; 25(5):620-30. PubMed ID: 26109490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicenter observational study assessing incidence and risk factors for acute blood transfusion reactions in dogs.
    Hall GBF; Birkbeck R; Brainard BM; Camacho F; Davidow EB; LeVine DN; Mackin A; Moss T; Nash KJ; Stanzani G; Starybrat D; Stoye DQ; Tai C; Thomason J; Walker JM; Wardrop KJ; Wilson H; Wurlod VA; Humm K
    J Vet Intern Med; 2024; 38(5):2495-2506. PubMed ID: 39239720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the patients with recurrent acute transfusion reactions: A single tertiary medical centre experience.
    Hsieh MY; Chen JS; Yin CH
    J Int Med Res; 2023 Jul; 51(7):3000605231181733. PubMed ID: 37421139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of transfusion reactions in postpartum blood transfusions.
    Thurn L; Wikman A; Westgren M; Lindqvist PG
    Blood Adv; 2019 Aug; 3(15):2298-2306. PubMed ID: 31366586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of pathogen-reduced platelet components without leukoreduction.
    Sim J; Tsoi WC; Lee CK; Leung R; Lam CCK; Koontz C; Liu AY; Huang N; Benjamin RJ; Vermeij HJ; Stassinopoulos A; Corash L; Lie AKW
    Transfusion; 2019 Jun; 59(6):1953-1961. PubMed ID: 30919465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence.
    Henrichs KF; Howk N; Masel DS; Thayer M; Refaai MA; Kirkley SA; Heal JM; Blumberg N
    Transfusion; 2012 Mar; 52(3):635-40. PubMed ID: 21895675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion treatment at Sestre Milosrdnice University Hospital Center during a twelve-year period.
    Sović D; Dodig J; Banović M; Jularić A
    Acta Clin Croat; 2014 Sep; 53(3):342-7. PubMed ID: 25509245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.